As of 23 Sept 2026, Mercury Laboratories Ltd share price is ₹817.00. The stock opened at ₹817.00 and had closed at ₹816.55 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹620.55 and a high of ₹942.90. In terms of performance, Mercury Laboratories Ltd share price has increased by 16.71% over the past six months and has decreased by 6.63% over the last year.
Mercury Labs Stock Price Chart
Mercury Laboratories Ltd Overview
About Mercury Labs
Mercury Laboratories is engaged into the manufacturing and export of wide range of Pharmaceutical items. The products of the company are in the segment of gynae and pediatrics.
Mercury Laboratories Ltd Historical Performance
Mercury Laboratories Ltd Fundamentals
Mercury Laboratories Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 77.90 | 76.17 | 76.65 | 77.05 | 58.74 |
| EBITDA | 10.60 | 8.09 | 10.12 | 10.28 | 7.93 |
| Net Profit | 4.83 | 3.14 | 5.65 | 5.58 | 3.56 |
| EPS | 40.28 | 26.21 | 47.12 | 46.49 | 29.68 |
Mercury Laboratories Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 785.37 |
| Resistance 1 (R1) | 865.87 |
| Pivot Point | 834.68 |
Mercury Laboratories Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 21-Sep-2026 | 29-May-2026 | 21-Sep-2026 | Final | ₹3.50 |
| 06-Aug-2025 | 14-May-2025 | 06-Aug-2025 | Final | ₹3.50 |
| 20-Sep-2024 | 28-May-2024 | 21-Sep-2024 | Final | ₹3.50 |
| 20-Sep-2023 | 05-May-2023 | 21-Sep-2023 | Final | ₹3.50 |
| 19-Sep-2022 | 26-May-2022 | 21-Sep-2022 | Final | ₹3.50 |
Mercury Laboratories Ltd Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Rajendra R Shah | Managing Director |
| Dilip R Shah | Non Executive Independent Director |
| Paresh Mistry | Non Executive Independent Director |
Mercury Laboratories Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,846.40-1.20% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,352.00-0.62% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,935.00-0.70% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Mercury Laboratories Ltd today is ₹817.00 on NSE and ₹817.00 on BSE.
- The 52-week high of Mercury Laboratories Ltd is ₹942.90, while the 52-week low is ₹620.55.
- The current market capitalisation of Mercury Laboratories Ltd is approximately ₹98 crore.
- The P/E (Price-to-Earnings) ratio of Mercury Laboratories Ltd is 23.54. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Mercury Laboratories Ltd is 1.69. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Mercury Laboratories Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Mercury Labs on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Mercury Laboratories Ltd has delivered a return of approximately 3.75%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Mercury Laboratories Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 73.66% promoters, 0.00% FIIs, 0.00% DIIs, and 16.58% public shareholders.

